CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Financial Officer Atabak Mokari sold $2.8M of Corcept Therapeutics Incorporated
Sold$2,800,004
$70.00Price
40,000Shares
−72%Stake
What CORT did after the filing
- The stock from Thu, Jun 4 open, $72.79
- +25.8%
- S&P 500, same days
- −1.3%
Measured over 30 trading days, to the Jul 20 close.
Traded Mon, Jun 1. Filed Wed, Jun 3, 7:20 PM ET, after the close. Returns use the Jun 4 open and the Jul 20 close. Not investment advice.